Amgen inc. (AMGN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

7,842

8,394

1,979

7,722

6,939

5,158

5,081

4,345

3,683

4,627

4,605

4,052

3,078

Depreciation, amortization and other

2,206

1,946

1,955

2,105

2,108

2,092

1,286

1,088

1,060

1,017

1,049

1,073

1,202

Write-off of acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

590

Share-based Payment Arrangement, Noncash Expense

308

311

329

311

322

408

403

362

341

353

284

262

263

Deferred income taxes

-289

-363

-1,330

183

607

108

189

-28

328

151

-47

137

-56

Property, plant and equipment impairments

-

-

-

-

-

-

-

178

6

118

21

59

404

Dividend received from equity investee

-

-

-

-

-

-

-

-

-

-

110

8

76

Other items, net

-186

386

334

-32

146

-56

-199

74

-63

-140

-111

244

173

Changes in operating assets and liabilities, net of acquisition:
Trade receivables, net

504

378

58

214

420

-136

38

-348

557

210

36

-65

-38

Inventories

66

3

-133

80

-481

-327

7

150

383

-153

134

59

109

Other assets

-10

-35

24

128

-155

1

59

-124

204

-20

3

-15

119

Accounts payable

164

-143

424

-44

-12

228

60

161

-95

142

71

95

-181

Accrued income taxes, net

-585

-361

523

-301

509

-103

-326

87

-20

-656

-142

14

-810

Long-term tax liabilities

-146

258

6,681

445

409

-

-

-

-

-

-

-

-

Legal reserve

-

-

-

-

-

-

-

-780

780

0

0

-

-

Other liabilities

396

1,214

231

323

-7

759

116

165

773

234

353

-30

688

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

327

52

Net Cash Provided by (Used in) Operating Activities

9,150

11,296

11,177

10,354

9,731

8,952

6,526

5,882

5,119

5,787

6,336

5,988

5,401

Cash flows from investing activities:
Purchases of marketable securities

9,394

18,741

33,607

28,094

25,977

25,878

21,965

26,241

21,183

14,602

12,418

10,345

5,579

Proceeds from sales of marketable securities

8,842

28,356

24,240

17,958

18,029

16,697

19,123

17,372

20,871

10,485

8,252

6,762

5,073

Purchases of intangible assets

-

-

-

-

-

285

0

25

-

-

-

-

-

Proceeds from maturities of marketable securities

20,548

5,412

6,174

2,459

3,527

4,199

5,090

1,994

749

642

1,443

1,018

454

Purchases of property, plant and equipment

618

738

664

738

594

718

693

689

567

580

530

672

1,267

Cash paid for acquisitions, net of cash acquired

13,617

-195

19

0

359

165

9,434

2,390

701

0

0

56

697

Proceeds from sales of property, plant and equipment

-

-

-

-

274

3

20

-

-

-

-

-

-

Change in restricted investments, net

-

-

-

-

-

-533

520

0

0

-

-

-

-

Other

52

145

148

243

447

138

90

11

-45

97

-51

-128

-24

Net cash (used in) provided by investing activities

5,709

14,339

-4,024

-8,658

-5,547

-5,752

-8,469

-9,990

-786

-4,152

-3,202

-3,165

-1,992

Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt

0

0

4,476

7,318

3,465

4,476

8,054

4,933

10,387

2,471

1,980

991

3,982

Repayments of Long-term Debt

4,500

1,100

4,400

3,700

2,400

5,605

3,371

123

2,500

0

1,000

2,000

1,840

Net proceeds from issuance of commercial paper

-

-

-

-

-

-

-

-

762

0

0

-

-

Repayments of commercial paper

-

-

-

-

-

-

-

-

762

0

0

-

-

Repurchases of common stock

7,702

17,794

3,160

2,965

1,867

138

832

4,607

8,315

3,786

3,208

2,268

5,100

Dividends paid

3,509

3,507

3,365

2,998

2,396

1,851

1,415

1,118

500

0

0

-

-

Settlement of contingent consideration obligations

-

-

-

-

253

92

0

-

-

-

-

-

-

Net proceeds from issuance of common stock in connection with the Companys equity award programs

-

-

-

-

-

186

296

1,288

242

80

-

155

277

Withholding taxes arising from shares withheld for share-based payments

137

126

191

260

401

225

139

-

-

-

-

-

-

Other

95

58

51

31

81

-25

-102

46

12

3

204

49

13

Net cash used in financing activities

-15,767

-22,490

-6,594

-2,599

-3,771

-3,274

2,491

419

-674

-1,232

-2,024

-3,073

-2,668

(Decrease) increase in cash and cash equivalents

-908

3,145

559

-903

413

-74

548

-3,689

3,659

403

1,110

-250

741